Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
Mediterranean Journal of Hematology and Infectious Diseases
|
January 21, 2017
Follicular Lymphoma: The Management of Elderly Patient
Alessia Castellino, Elisa Santambrogio, Maura Nicolosi, et al.
Cancers
|
January 11, 2025
Bispecific Antibodies for Lymphoid Malignancy Treatment
Matteo Bisio, Luca Legato, Filippo Fasano, et al.
SN Comprehensive Clinical Medicine
|
August 4, 2021
COVID-19 and Aspiration Pneumonia: Similar Pulmonary Findings with Different Diagnoses-a Pitfall in [18F]FDG PET/CT
Virginia Liberini, Serena Grimaldi, Martin W Huellner, et al.
Cancers
|
May 25, 2024
Advances in Hodgkin Lymphoma Treatment: From Molecular Biology to Clinical Practice
Corrado Benevolo Savelli, Matteo Bisio, Luca Legato, et al.
Annals of Hematology
|
April 18, 2018
Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience
Chiara Ciochetto, Barbara Botto, Roberto Passera, et al.
The British Journal of Radiology
|
June 11, 2021
Efficacy of low-dose radiotherapy (2 Gy × 2) in the treatment of marginal zone and mucosa-associated lymphoid tissue lymphomas
Marzia Cerrato, Erika Orlandi, Angelisa Vella, et al.
Journal of Personalized Medicine
|
April 3, 2021
Real Life Use of Bendamustine in Elderly Patients with Lymphoid Neoplasia
Irene Dogliotti, Simone Ragaini, Francesco Vassallo, et al.
Frontiers in Oncology
|
March 27, 2023
Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi
Gloria Margiotta-Casaluci, Sara Bigliardi, Federica Cocito, et al.
Haematologica
|
June 14, 2005
High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial
Umberto Vitolo, Anna Marina Liberati, Maria Giuseppina Cabras, et al.
American Journal of Hematology
|
October 21, 2014
The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana Linfomi
Giuseppe Rossi, Luigi Marcheselli, Alessandra Dondi, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
Mediterranean Journal of Hematology and Infectious Diseases
|
January 21, 2017
Follicular Lymphoma: The Management of Elderly Patient
Alessia Castellino, Elisa Santambrogio, Maura Nicolosi, et al.
Cancers
|
January 11, 2025
Bispecific Antibodies for Lymphoid Malignancy Treatment
Matteo Bisio, Luca Legato, Filippo Fasano, et al.
SN Comprehensive Clinical Medicine
|
August 4, 2021
COVID-19 and Aspiration Pneumonia: Similar Pulmonary Findings with Different Diagnoses-a Pitfall in [18F]FDG PET/CT
Virginia Liberini, Serena Grimaldi, Martin W Huellner, et al.
Cancers
|
May 25, 2024
Advances in Hodgkin Lymphoma Treatment: From Molecular Biology to Clinical Practice
Corrado Benevolo Savelli, Matteo Bisio, Luca Legato, et al.
Annals of Hematology
|
April 18, 2018
Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience
Chiara Ciochetto, Barbara Botto, Roberto Passera, et al.
The British Journal of Radiology
|
June 11, 2021
Efficacy of low-dose radiotherapy (2 Gy × 2) in the treatment of marginal zone and mucosa-associated lymphoid tissue lymphomas
Marzia Cerrato, Erika Orlandi, Angelisa Vella, et al.
Journal of Personalized Medicine
|
April 3, 2021
Real Life Use of Bendamustine in Elderly Patients with Lymphoid Neoplasia
Irene Dogliotti, Simone Ragaini, Francesco Vassallo, et al.
Frontiers in Oncology
|
March 27, 2023
Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi
Gloria Margiotta-Casaluci, Sara Bigliardi, Federica Cocito, et al.
Haematologica
|
June 14, 2005
High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial
Umberto Vitolo, Anna Marina Liberati, Maria Giuseppina Cabras, et al.
American Journal of Hematology
|
October 21, 2014
The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana Linfomi
Giuseppe Rossi, Luigi Marcheselli, Alessandra Dondi, et al.
Page
of 4